Should I Buy AEMD Stock in 2026?

Data-driven analysis and honest assessment for Aethlon Medical Inc

Analysis Updated:
HOLDMixed signals - suitable for existing holders

Current Price: $2.70P/E: 0.0

Decision Score

5.6/10

Hold

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)9/10

Very low P/E of 0.0 suggests undervaluation

Growth (20%)9/10

Strong growth of 21%

Profitability (20%)2/10

Currently unprofitable

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)2/10

Negative free cash flow

Insider Activity (10%)5/10

No recent insider activity

Key Investment Metrics

Current Price

$2.70

P/E Ratio

0.01

Revenue Growth

42.8%

Profit Margin

N/A

Market Cap

$0.0B

Dividend Yield

None

How AEMD Compares to Competitors

Understanding how AEMD stacks up against peers helps inform your investment decision.

How AEMD Compares to Peers

Upcoming Events for AEMD

+5 Reasons TO Buy AEMD

1. Attractively valued at 0.0x earnings

strong

A P/E ratio of 0.0 is below the market average of ~20x, suggesting the stock may be undervalued.

2. Revenue growing 43% year-over-year

strong

Strong top-line growth indicates robust demand and expanding market opportunity.

3. High gross margins of 100%

strong

Gross margins above 50% typically indicate strong brand value or intellectual property moats.

-5 Reasons NOT to Buy AEMD

1. Negative free cash flow

high risk

Burning cash creates funding risk and limits shareholder returns.

2. Small-cap volatility risk

high risk

Market cap under $2B means higher volatility and lower liquidity.

Who Should Buy AEMD?

Investment Profile

Risk Level

Very High

Recommended Holding Period

3-5 years

Best For:

  • Growth Investors

    43% revenue growth aligns with growth strategies

  • Momentum Traders

    High-growth profile attracts momentum

Not Suitable For:

  • Income-Focused Retirees

    No dividend paid

  • Risk-Averse Investors

    Very High risk may cause uncomfortable volatility

  • Large Position Traders

    Lower liquidity may impact execution

Consider These Alternatives

If you're interested in AEMD, compare these Health Care peers:

Pro tip: Compare AEMD directly with competitors using our comparison tool to see which stock better fits your criteria.

Get the Full Picture

Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for AEMD

Frequently Asked Questions

What is AEMD stock price today?

AEMD (Aethlon Medical Inc) stock is trading at $2.70 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is AEMD stock going up or down today?

AEMD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AEMD stock now?

The decision to buy AEMD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AEMD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AEMD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AEMD stock overvalued or undervalued?

AEMD currently trades at a P/E ratio of 0.01, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if AEMD is fairly priced.

What is AEMD's P/E ratio?

AEMD has a price-to-earnings (P/E) ratio of 0.01, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is AEMD's market cap?

AEMD (Aethlon Medical Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is AEMD's price to book ratio?

AEMD trades at a price-to-book (P/B) ratio of 0.49, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Similar Investment Decisions

Explore investment analyses for stocks similar to Aethlon Medical Inc

Explore Categories

Disclaimer

This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.